Jayari, Asmer E.

HRN: 29-23-23  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/02/2026
07/10/2026
IV
20mg
Q8
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: